Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Aug 15, 2003; 9(8): 1808-1814
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1808
Table 4 The viability of PS-ODNs treated P3 cells (%, -x±s)
PS-ODNC1(3.16) V(%,-x±s)C2(10) V(%,-x±s)C3(31.6) V(%,-x±s)C4(100) V(%,-x±s)
PS-ODN192.16 ± 4.280.39 ± 5.958.11 ± 3.433.34 ± 4.6
PS-ODN293.40 ± 2.684.22 ± 3.674.10 ± 3.827.35 ± 2.4
PS-ODN391.74 ± 4.188.75 ± 7.186.38 ± 6.781.37 ± 5.3
PS-ODN494.23 ± 3.392.36 ± 5.293.72 ± 4.991.54 ± 4.4